JPRN-UMIN000001643已完成未知
Trial of Proteinuria Reduction Effect of Losartan/Hydrochlorothiazide Therapy to Chronic Kidney Disease with Hypertension - Trial of Proteinuria Reduction Effect of Losartan/Hydrochlorothiazide to CKD patients
Kyushu University Hospital Kidney Care Unit0 个研究点目标入组 120 人开始时间: 2009年1月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with uncontrolled hypertension, serum patassium >5.5 mEq/L, cardiovascular disease (myocardial infarction, unstable angina, stroke within last 3 months), pregnancy,lactation,nephrotic syndrome (serum Alb <2g/dl), frequent users of diuretics are excluded.
研究者
相似试验
已完成
3 期
Efficacy and Safety of Losartan in Children With Ig A NephropathyGlomerulonephritis, IGANCT02232776Seoul National University Hospital37
已完成
4 期
Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)Renal DisorderNCT00140985Organon and Co97
已完成
3 期
Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular ProteinuriaProteinuriaNCT02232763Seoul National University Hospital58
招募中
不适用
Impact of azilsartan on proteinuria in patients with chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000008597Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University160
已完成
3 期
Investigation Effect of losartan NAFLD patientsAFLD.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20180412039283N1Shahid Beheshti University of Medical Sciences250